quinazolines has been researched along with Fra(X) Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Barmada, SJ; Flores, BN; Green, KM; Ivanova, MI; Kearse, MG; Sheth, UJ; Sutter, AB; Todd, PK; Wright, SE | 1 |
Heldermon, CD; Kitada, K; Koyama, M; Meacham, AM; Pacak, CA; Santostefano, KE; Tachibana, D; Terada, N; Waldrop, SM; Watanabe, N; Yokoyama, A | 1 |
2 other study(ies) available for quinazolines and Fra(X) Syndrome
Article | Year |
---|---|
High-throughput screening yields several small-molecule inhibitors of repeat-associated non-AUG translation.
Topics: Amyotrophic Lateral Sclerosis; Animals; Ataxia; Azepines; Cells, Cultured; Circular Dichroism; DNA Repeat Expansion; Drug Evaluation, Preclinical; Fragile X Syndrome; HEK293 Cells; Humans; Neurodegenerative Diseases; Propidium; Pyrimidines; Quinazolines; Rats; Tremor; Trinucleotide Repeat Expansion | 2019 |
Generation of Induced Pluripotent Stem Cells from a Female Patient with a Xq27.3-q28 Deletion to Establish Disease Models and Identify Therapies.
Topics: Cell Differentiation; Cells, Cultured; Child, Preschool; Chromosome Deletion; Chromosomes, Human, X; Decitabine; Developmental Disabilities; Female; Fragile X Mental Retardation Protein; Fragile X Syndrome; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Induced Pluripotent Stem Cells; Intellectual Disability; Quinazolines | 2020 |